Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Charlie Mains as vice-president of business development.

Mains has worked in the clinical trial technology industry for more than 20 years. He was previously senior director of strategic alliances at Thread, a research platform which supports pharma organisations to capture data around in-clinic visits, and as the senior director of business development for CRF Health’s Strategic Accounts Group.

Alex Livingstone-Learmonth, chief commercial officer at Cambridge Cognition said: “Charlie’s leadership skills, significant expertise and successful track record make him the ideal candidate to accelerate our business development activities, as we continue to drive growth and develop our significant pipeline of new opportunities.”

Mains commented: “Within the dynamic world of CNS research, I am confident that I will be able to leverage my wealth of experience to the benefit of the wider team and help to continue to develop the pipeline. I look forward to joining the team to support Cambridge Cognition’s growth and, ultimately, help improve CNS research worldwide.”